arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Keros Therapeutics, Inc.

KROS

$11.13 ▲ +0.47 (+4.41%) at close

30 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

Keros Therapeutics, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $218.5M

Dividend Yield —

Revenue Growth -99.8% ↘

Op. Margin None

ROIC -9.1% →

FCF / Share $-0.18

Trailing P/E —

Price / Book 0.8x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

30-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$367.00K

↓ -99.8% —

Net Income Profit after all expenses

$-23.71M

↓ -1.1% —

Operating Margin Operating profit as % of sales

-107.9%

↑ +50.8% 84th

FCF / Share Free cash flow per share

$-0.18

↓ -339.1% —

trending_up

Bullish Indicators

Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue Growth YoY (%)	-99.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1348%)	-87.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1192%)	3575.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+44597%)	49002.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+612434%)	254413.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3180066%)	2027.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+25241%)	4750.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+59275%)	—	—	—	—	—	—	N/M	—	N/M	—	—	—	—	—	N/M	N/M	N/M	N/M	—	—	—	—	—
EPS Growth YoY (%)	N/M	66.1% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	87.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	39.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	16.4% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-6.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	1.6% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	4.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-21.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-44.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-12.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-24.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-266.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-5.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-68.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	-7.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-45.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-8.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	49.0% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	-14.4% Weak ↑ Weak Improving Year-over-year change in net income	-20.4% Weak ↑ Weak Improving Year-over-year change in net income	-20.4% Weak ↑ Weak Improving Year-over-year change in net income	-20.4% Weak ↑ Weak Improving Year-over-year change in net income	-35.4% Weak ↑ Weak Improving Year-over-year change in net income	-48.0% Weak ↑ Weak Improving Year-over-year change in net income	-48.0% Weak ↑ Weak Improving Year-over-year change in net income	-48.0% Weak ↑ Weak Improving Year-over-year change in net income	-328.2% Weak ↓ Weak Declining Year-over-year change in net income	-52.3% Weak ↓ Weak Declining Year-over-year change in net income	-52.3% Weak ↓ Weak Declining Year-over-year change in net income	-52.3% Weak ↓ Weak Declining Year-over-year change in net income	35.0% Excellent ↑ Excellent Improving Year-over-year change in net income	-33.6% Weak ↑ Weak Improving Year-over-year change in net income	-33.6% Weak ↑ Weak Improving Year-over-year change in net income	-33.6% Weak ↑ Weak Improving Year-over-year change in net income	-288.1% Weak ↓ Weak Declining Year-over-year change in net income	-273.6% Weak → Weak Stable Year-over-year change in net income	-273.6% Weak Weak Year-over-year change in net income	-273.6% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	N/M	—	N/M	32.8% Excellent Excellent Year-over-year change in free cash flow	N/M	—	—	—	-2.5% Weak Weak Year-over-year change in free cash flow	—	—	—	-1796.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	-46.6% Weak Weak Compound annual revenue growth over 3 years	—	-28.2% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	—	4.0% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	-31.1% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-56.9% Weak Weak Compound annual revenue growth over 5 years	-49.4% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Operating Margin (%) (%)	—	—	-107.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-819%)	-219.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1561%)	72.0% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+380%)	—	—	—	—	—	—	—	—	—	—	—	—	-24.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-262%)	—	—	—	—	—	—	—	-109.1% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-827%)	-93.0% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-720%)	-106.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-807%)	-114.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-862%)	—
Effective Tax Rate (%) (%)	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	16.4% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.3% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-40.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.4% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	—	—	—	—	70.3% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+486%)	—	—	—	—	—	—	—	—	—	—	—	—	-34.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-389%)	—	—	—	—	—	—	—	-110.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1017%)	-127.3% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1161%)	-127.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1161%)	-127.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1161%)	—
FCF Margin (%) (%)	—	—	21.9% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-167.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	76.0% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	-98.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	-220.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-121.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-208.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-100.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.99x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.07x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	2.84x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.01x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.63x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	-9.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-1.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	19.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-12.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-6.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	41.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	14.0% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	13.9% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	20.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	27.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-8.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-2.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	19.4% Excellent Excellent Operating profit relative to total assets Optimal: > 10%	-8.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-10.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-11.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-4.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-17.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-24.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-8.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-7.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	21.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+41%)	21.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+40%)	20.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+36%)	-8.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-8.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-10.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-168%)	-9.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-12.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-12.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-11.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-10.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-10.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-10.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-11.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-10.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-2.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-119%)	-7.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-6.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	-6.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)	-4.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	-9.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-8.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-156%)	47.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+219%)	14.1% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-6%)	19.0% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+27%)	24.1% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+61%)	30.7% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+105%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-24126.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4866.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-20197.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15541.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15769.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13291.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5974.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10914.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5252.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-775.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1325.50x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1429.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-281.50M	$-287.42M	$-693.47M	$-690.22M	$-720.54M	$-559.93M	$-530.68M	$-405.86M	$-442.44M	$-331.15M	$-287.89M	$-322.03M	$-351.43M	$-279.05M	$-239.43M	$-215.62M	$-228.59M	$-230.04M	$-221.35M	$-237.11M	$-255.20M	$-265.88M	$-133.81M	$-144.69M	$-54.52M	$-7.02M	$-12.53M	$-15.55M	$-20.75M	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	$0.02	—	$0.35	$0.45	$5.21	—	$0.01	$0.00	$0.00	—	$0.00	—	—	—	$0.00	$0.00	—	—	$0.00	$0.00	—	—	$0.00	$0.00	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.21	$-0.38	$-0.18	$-0.76	$3.66	$-1.12	$-1.41	$-1.25	$-1.21	$-1.34	$-1.33	$-1.27	$-1.26	$-1.10	$-0.92	$-1.13	$-1.01	$-0.30	$-0.87	$-0.67	—	$-0.28	$-0.60	$-0.62	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.18	—	$0.08	$-0.75	$3.96	—	$-0.82	$-1.11	$-1.28	—	—	—	$-1.24	—	—	—	$-0.07	—	—	—	—	—	$-0.54	$-0.56	—	—	—	—	—	—
Book Value per Share (USD)	$14.47	$15.51	$17.32	$17.40	$17.97	$14.09	$14.17	$11.66	$12.59	$10.43	$9.97	$11.00	$12.01	—	$9.24	$8.65	$9.31	—	$9.34	$10.10	$10.67	$11.28	$6.48	$8.02	$-9.98	$-8.00	—	—	—	—
Tangible Book Value per Share (USD)	$14.47	$15.51	$17.32	$17.40	$17.97	$14.09	$14.17	$11.66	$12.59	$10.43	$9.97	$11.00	$12.01	—	$9.24	$8.65	$9.31	—	$9.34	$10.10	$10.67	$11.28	$6.48	$8.02	$-9.98	$-8.00	—	—	—	—
Basic Weighted Avg Shares (shares)	19.63M	—	40.62M	40.61M	40.56M	—	37.59M	36.10M	35.69M	—	29.67M	29.60M	28.37M	—	25.55M	24.05M	23.99M	—	23.36M	23.31M	—	—	20.18M	17.62M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$277.82M	$295.02M	$695.22M	$698.10M	$720.13M	$561.44M	—	—	$444.41M	$322.92M	$287.73M	$318.21M	$346.76M	—	$234.35M	$206.90M	$219.57M	—	$215.06M	$233.89M	$247.03M	$260.54M	—	—	$49.70M	$4.44M	—	—	—	—
Total Equity (USD)	$285.63M	$303.13M	$703.58M	$706.73M	$728.87M	$571.55M	$532.84M	$420.92M	$453.95M	$332.21M	$295.84M	$326.26M	$354.98M	$277.42M	$241.03M	$211.21M	$223.49M	$243.17M	$218.48M	$235.66M	$248.37M	$261.72M	$130.76M	$141.36M	$-24.87M	$-19.45M	$-16.72M	$-13.19M	$-10.36M	$-7.18M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	$367.00K	$385.00K	$14.26M	$18.17M	$211.25M	$3.04M	$388.00K	$37.00K	$83.00K	$143.00K	$8.00K	—	—	$0.00	$0.00	$0.00	—	$20.00M	$0.00	$100.00K	—	$0.00	$0.00	$0.00	$0.00	$2.50M	$2.50M	$2.50M	$2.50M	—
Depreciation Expense (USD)	$403.00K	$400.00K	$395.00K	$370.00K	$344.00K	$332.00K	$314.00K	$306.00K	$277.00K	$247.00K	—	—	$167.00K	$127.00K	—	—	$113.00K	$104.00K	—	—	$80.00K	$75.00K	$72.00K	$68.00K	$63.00K	$59.00K	$55.00K	$49.00K	$45.00K	—
Net Income, GAAP (USD)	$-23.71M	$-23.46M	$148.45M	$148.45M	$148.45M	$-46.03M	$-43.11M	$-43.11M	$-43.11M	$-40.24M	$-35.80M	$-35.80M	$-35.80M	$-29.72M	$-24.19M	$-24.19M	$-24.19M	$-6.94M	$-15.88M	$-15.88M	$-15.88M	$-10.68M	$-11.89M	$-11.89M	$-11.89M	$-2.75M	$-3.18M	$-3.18M	$-3.18M	—
Operating Cash Flow (USD)	$-3.53M	$-27.29M	$3.25M	$-29.62M	$161.17M	$-46.01M	$-30.50M	$-39.80M	$-44.56M	$-25.46M	—	—	$-34.23M	$-21.44M	—	—	$-1.43M	$-19.57M	—	—	$-10.51M	$-7.99M	$-10.86M	$-9.93M	$-8.12M	$-5.50M	$-2.96M	$-5.03M	$-2.51M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 30 quarters

Keros Therapeutics, Inc.

Analytical Summary

30-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare KROS with peers